A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy-Reference-Cited by-同舟云学术

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

Published:2013-10-22 Issue:1 Volume:17 Page:64-69
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Ross A E,Feng F Y,Ghadessi M,Erho N,Crisan A,Buerki C,Sundi D,Mitra A P,Vergara I A,Thompson D J S,Triche T J,Davicioni E,Bergstralh E J,Jenkins R B,Karnes R J,Schaeffer E M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/pcan201349.pdf

Reference31 articles.

1. Siegel R, Naishadham D, Jemal A . Cancer statistics 2012. Cancer Stat 2012; 62: 10–29.

2. Cooperberg MR, Broering JM, Carroll PR . Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010; 28: 1117–1123.

3. Moul J . Prostate specific antigen only progression of prostate cancer. J Urol 2000; 163: 1632–1642.

4. Punnen S, Cooperberg MR, D’Amico A V, Karakiewicz PI, Moul JW, Scher HI et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol 2013; (e-pub ahead of print).

5. Antonarakis ES, Feng Z, Trock BJ, Humphreys EB, Carducci M a, Partin AW et al. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up. BJU Int 2012; 109: 32–39.

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk;npj Precision Oncology;2024-02-23

2. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

3. Distinct mesenchymal cell states mediate prostate cancer progression;Nature Communications;2024-01-08

4. PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma;Technology in Cancer Research & Treatment;2024-01

5. An 18-Gene Algorithm urine test for predicting prostate cancer metastasis and castration- resistance;2023-10-13